electroCore, Inc. Common Stock ECOR
$9.94
+0.81%
at last close
Market Cap$81.80 million
P/E Ratio—
Div Yield—
Volume422.9K
52-Week Range
$4.16$10.37
Key Stats
- Today's Range
- $9.03 – $10.13
- 50-Day Range
- $5.62 – $10.37
- 52-Week Range
- $4.16 – $10.37
- Volume
- 423K shs
- Average Volume
- 125K shs
- Market Cap
- $81.80 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- -14.38
- Price / Sales
- 2.34
Short Interest
- Short Interest
- 0.23%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $34.90 million
- Net Income
- $-15,382,000
- Net Margin
- -44.08%
- Return on Equity
- 270.43%
- Debt-to-Equity
- -1.36
About electroCore, Inc. Common Stock
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.